Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Telegraph Hill Partners
AddedFeb 15, 2024
UpdatedJun 28, 2026
Telegraph Hill Partners

Telegraph Hill Partners

Operating

Telegraph Hill Partners: A US-based private equity firm specializing in life science, medical, and healthcare sectors.

Location
San Francisco, CA, US
Founded
2002
Firm
Compare
Portfolio
Employees
Website

Telegraph Hill Partners is a private equity firm specializing in life science, medical device, and healthcare companies in the United States. The firm typically invests across various stages, including Series A, B, and later rounds, with a focus on growth-stage opportunities. Their investment strategy encompasses a wide range of healthcare-related sectors, demonstrating a commitment to advancing innovative technologies and solutions in these fields.

Notable portfolio companies include Akoya Biosciences, Carterra, and RareCyte, reflecting the firm's emphasis on cutting-edge life science and medical technologies. Telegraph Hill Partners provides not only capital but also strategic guidance and industry expertise to help portfolio companies accelerate growth and achieve market leadership. The firm's investment approach is characterized by a hands-on partnership model, leveraging their deep sector knowledge to support portfolio companies' development and expansion.

Telegraph Hill Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments20
Current Portfolio Count13
Total Portfolio Exits0

Top Investment Stages

Series Unknown14 (73.7%)
Series A2 (10.5%)
Pre-Seed1 (5.3%)
Series B1 (5.3%)
Series D1 (5.3%)

Stage Mix

Series Unknown 74%Series A 11%Pre-Seed 5%Series B 5%Series D 5%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Cell Microsystems logo

Cell Microsystems

Panome Bio logo

Panome Bio

Emerging Therapy Solutions logo

Emerging Therapy Solutions

Mosaic Biosciences logo

Mosaic Biosciences

Excellos logo

Excellos

Carterra logo

Carterra

Nivagen Pharmaceuticals logo

Nivagen Pharmaceuticals

Akoya Biosciences logo

Akoya Biosciences

Specific Diagnostics logo

Specific Diagnostics

Nimble Therapeutics logo

Nimble Therapeutics

Invisalert Solutions logo

Invisalert Solutions

Aquaro Histology logo

Aquaro Histology

RareCyte logo

RareCyte

Telegraph Hill Partners - Similar Investment Firms

Telegraph Hill Capital logo

Telegraph Hill Capital

thcap.com

Great Hill Partners logo

Great Hill Partners

Kline Hill Partners logo

Kline Hill Partners

klinehill.com

Summit Partners logo

Summit Partners

summitpartners.com

Granite Hill Capital Partners logo

Granite Hill Capital Partners

granitehill.net

Snow Hill Partners logo

Snow Hill Partners

snowhill.vc

Cove Hill Partners logo

Cove Hill Partners

Alta Partners logo

Alta Partners

altapartners.com

City Hill Ventures logo

City Hill Ventures

Bay Partners logo

Bay Partners

baypartners.com

Telescope Partners logo

Telescope Partners

Francisco Partners logo

Francisco Partners

Foresite Capital logo

Foresite Capital

Twilight Venture Partners logo

Twilight Venture Partners

Prospect Hill Growth Partners logo

Prospect Hill Growth Partners

Telegraph Hill Partners - Classification

Also Known As
  • Telegraph Hill Partners Management Company, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end